EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacology of Senolytics: Targeting Cellular Aging in Chronic Diseases

Priyanka R.Chaudhari

International Journal of Sciences and Innovation Engineering · 2025

DOI: 10.70849/ijsci02092025077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Sciences and Innovation Engineering, 2025. Verfasst von Priyanka R.Chaudhari. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence is a state of irreversible cell cycle arrest characterized by the secretion of pro-inflammatory mediators collectively termed the senescence-associated secretory phenotype (SASP). Although senescence plays a physiological role in tissue repair and tumor suppression, the accumulation of senescent cells during aging contributes to chronic low-grade inflammation and the pathogenesis of several age-related diseases. Senolytics, a novel class of pharmacological agents, selectively eliminate senescent cells and represent a promising therapeutic approach to delay aging and mitigate chronic disorders. This review provides an overview of the pharmacological basis of senolytics, highlighting their mechanisms of action, therapeutic potential, and current challenges. Small molecules such as dasatinib, navitoclax, and FOXO4-DRI peptides, as well as natural compounds including quercetin, fisetin, and curcumin, have demonstrated senolytic activity by targeting anti-apoptotic pathways, modulating mitochondrial function, and reducing SASP-mediated inflammation. Preclinical studies show their efficacy in cardiovascular disease, diabetes, osteoarthritis, neurodegeneration, and cancer, while early clinical trials suggest benefits in idiopathic pulmonary fibrosis and frailty. Despite their promise, limitations such as off-target effects, biomarker identification, and long-term safety remain critical barriers. Future perspectives include personalized senolytic therapy, integration with senomorphics, and nanotechnology-based delivery systems. Senolytics thus hold significant potential in transforming pharmacological management of chronic diseases.

Zitieren

APA

R.Chaudhari, P. (2025). Pharmacology of Senolytics: Targeting Cellular Aging in Chronic Diseases. International Journal of Sciences and Innovation Engineering. https://doi.org/10.70849/ijsci02092025077

Vancouver

R.Chaudhari P. Pharmacology of Senolytics: Targeting Cellular Aging in Chronic Diseases. International Journal of Sciences and Innovation Engineering. 2025. doi:10.70849/ijsci02092025077

BibTeX
@article{RChaudhari2025,
  author = {R.Chaudhari, Priyanka},
  title = {Pharmacology of Senolytics: Targeting Cellular Aging in Chronic Diseases},
  journal = {International Journal of Sciences and Innovation Engineering},
  year = {2025},
  doi = {10.70849/ijsci02092025077}
}
Kostenlos starten →